| Filed On | Filing |
|---|---|
| 15 Oct 2026 |
8-K: Other Events
Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy |
| 07 Oct 2026 |
8-K: Other Events
REDWOOD CITY, Calif., October 7, 2026 (GLOBE NEWSWIRE) – Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper” or the “Company”), a clinical stage biotechnology company focused on the design and development of innovative therapies to treat ... |
| 05 Oct 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On September 30, 2026, Jasper Therapeutics, Inc. (the “Company”) held a special meeting of stockholders (the “Special Meeting”). At the Special Meeting, a total of 21,747,865 shares of the Company’s voting common stock, $0.0001 par value... |
| 28 Sep 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
On September 23, 2026, Herb Cross submitted his resignation, effective as of October 9, 2026, as Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer and Corporate Secretary of Jasper Therapeutics, Inc. (the... |
| 26 Aug 2026 | 8-K: Entry into a Material Definitive Agreement |
| 14 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 03 Aug 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 31 Jul 2026 | 8-K: Other Events |
| 17 Jul 2026 | 8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +4 more |
| 16 Jul 2026 | 8-K: Regulation FD Disclosure |
| 09 Jun 2026 | 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule |
| 01 Jun 2026 | 8-K: Regulation FD Disclosure |
| 21 May 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 14 May 2026 | 8-K: Results of Operations and Financial Condition |
| 30 Mar 2026 | 8-K: Results of Operations and Financial Condition |
| 08 Jan 2026 | 8-K: Other Events |
| 07 Jan 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Other Events |
| 02 Dec 2025 | 8-K: Other Events |
| 10 Nov 2025 | 8-K: Results of Operations and Financial Condition |
| 19 Sep 2025 | 8-K: Entry into a Material Definitive Agreement; Other Events |
Loading...
